Clinical Trial Update: A Phase II Study of Ziv-aflibercept in Combination With Capecitabine/Oxaliplatin (XELOX) Chemotherapy in the Front-Line Treatment of Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

This document notes withdrawal of a Phase II trial of ziv-aflibercept in combination with XELOX (capecitabine/oxaliplatin) for first-line metastatic colorectal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)
• Ziv-aflibercept (ziv-aflibercept)

Snippet

Sponsor: James J Lee | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: WITHDRAWN